z-logo
open-access-imgOpen Access
Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer
Author(s) -
Michael K.C. Lee,
Jonathan M. Loree
Publication year - 2019
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.26.6145
Subject(s) - medicine , colorectal cancer , oncology , alternative medicine , clinical trial , cancer , pathology
In the initially published manuscript, the article stated (about the BEACON clinical trial) that “Interestingly, the triplet did not appear more active than the combination of encorafenib and binimetinib (mos: 9.0 months vs. 8.4 months; HR: 0.79; 95% CI: 0.59 to 1.06).” [...]

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here